AC220 for Children With Relapsed/Refractory ALL or AML

Clinical trial NCT01411267 · COMPLETED

Trial details

NCT number: NCT01411267
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoblastic Leukemia, Acute, Childhood Myelogenous Leukemia, Acute, Childhood

Start date: 2011-09-01
Primary completion: 2013-09-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.